SWK Holdings Provides Portfolio Update Highlighting Recent Achievements
Specialty Finance Portfolio Growth, Underlying Credit Performance Highlight Strong 2020
Closed Four Transactions During 2020, Deploying $35 Million
Two Milestone Payments Received from Cara Therapeutics Related to the Development of Oral KORSUVA™
Fourth Quarter and Full-Year 2020 Financial Results Expected in March 2021
News provided by
Share this article
Share this article
DALLAS, Feb. 16, 2021 /PRNewswire/ SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided an update on the progress and achievements of its portfolio and partner companies during the past year. SWK s strong performance is highlighted by 20% year-over-year growth in our earning assets to approximately $208 million accompanied by strong underlying credit trends, stated Winston Black, Chairman and CEO of SWK Holdings. Du